Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
51.50
+1.24 (2.47%)
Aug 15, 2025, 3:44 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $227.24 billion as of August 15, 2025. Its market cap has decreased by -60.51% in one year.
Market Cap
227.24B
Enterprise Value
239.85B
Revenue
49.11B
Ranking
n/a
PE Ratio
13.00
Stock Price
$51.50
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 227.24B, an increase of 3,079.76%. That is a compound annual growth rate of 12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 227.24B | -41.10% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | 162.91B | 19.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |